| Stage | DAL | % of rev | RJET | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $20.2B | 100.00% | $554M | 100.00% | DAL ×36.47 |
| Gross profit | $5.6B | 27.86% | $189M | 34.13% | RJET +6.3pp |
| Operating income | $1.5B | 7.20% | $63M | 11.42% | RJET +4.2pp |
| Pre-tax income | $1.1B | 5.32% | $49M | 8.89% | RJET +3.6pp |
| Net income | $756M | 3.75% | $35M | 6.25% | RJET +2.5pp |
| Stage | DAL | RJET | Gap · A − B |
|---|---|---|---|
| Revenue | $20.2B100.00% | $554M100.00% | DAL ×36.47 |
| Gross profit | 27.86%$5.6B | 34.13%$189M | RJET +6.3pp |
| Operating income | 7.20%$1.5B | 11.42%$63M | RJET +4.2pp |
| Pre-tax income | 5.32%$1.1B | 8.89%$49M | RJET +3.6pp |
| Net income |
| 3.75%$756M |
| 6.25%$35M |
| RJET +2.5pp |
No shared counterparties.